D e s c r i p t i o n o f t e s t a n d d i a g n o s t i c s t a n d a r d
FPG levels were measured in venous plasma by the glucose-oxidase method (Boehringer-Mannheim, Mannheim, Germany) and by the glucose-dehydrogenase method (Merck, Darmstadt, Germany). HbA 1c was measured using high-perfor-mance liquid chromatography. The sensitivity and specificity of an FPG level of 7.8 mmol/L was calculated with reference to the HbA 1c diagnostic standard cut points of 6.5% and 7.0%. These cut points were chosen in accordance with guidelines of the European NIDDM Policy Group and the American Diabetes Association.
M a i n o u t c o m e m e a s u r e s
The predictive value of different levels of FPG as an indicator of HbA 1c level was analyzed using receiver-operating characteristic curves. Change in FPG level at 3 months was also assessed as an indicator of change in HbA 1c level.
M a i n r e s u l t s
For the 2 HbA 1c cut points that separated good from poor levels (6.5% and 7.0%), the areas under the curve did not differ (0.87 and 0.88, respectively; P = 0.35). An FPG level ≥ 7.8 mmol/L detected 90% of patients with an HbA 1c level ≥ 7.0%. An FPG level < 7.8 mmol/L detected 66% of patients with an HbA 1c level < 7.0%. A change in FPG levels at 3 months of ≤ 0 (i.e., no change or worsening) had a sensitivity of 57% and a specificity of 88% for detecting a deterioration in HbA 1c of > 0.5%.
C o n c l u s i o n s
In patients with type 2 diabetes mellitus who were not receiving insulin, fasting plasma glucose level was highly correlated with glycosylated hemoglobin level. Except at extreme values (< 7 and > 12 mmol/L), fasting plasma glucose level was too imprecise to substitute for glycosylated hemoglobin level as a measure of glycemic control. Other studies have noted that nonfasting glucose levels may more accurately predict poor glycemic control than do fasting levels. For example, HbA 1c levels were more highly correlated with post-lunch glucose levels (r = 0.81) than with fasting levels (r = 0.62), and postlunch glucose values of > 11.1 mmol/L (> 200 mg/dL) ruled in poor glycemic control (HbA 1c level > 7%) (2) .
Clinicians must also be mindful that HbA 1c values are not a perfect measure of glycemic control. There are substantial interindividual variations in the affinity of hemoglobin and glucose, and rapid erythrocyte turnover can give a false sense of good glycemic control.
